HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and The... HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies. Show more
New Leadership Appointments; Positive Clinical and Regulatory Reports for the Lead Product Candidate, HB-200 (eseba-vec); On track to initiate the Phase 2/3 “AVALON-1” study with eseba-vec in Q4...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.155 | -7.56097560976 | 2.05 | 2.18 | 1.895 | 65856 | 2.05951257 | CS |
4 | -0.505 | -21.0416666667 | 2.4 | 2.6003 | 1.88 | 58399 | 2.27770954 | CS |
12 | -2.345 | -55.3066037736 | 4.24 | 4.32 | 1.88 | 53770 | 2.98335151 | CS |
26 | -4.555 | -70.6201550388 | 6.45 | 6.783 | 1.88 | 86659 | 4.89762555 | CS |
52 | -5.115 | -72.967189729 | 7.01 | 10.5 | 1.88 | 424179 | 7.55306149 | CS |
156 | -23.205 | -92.4501992032 | 25.1 | 30.5 | 1.88 | 1206881 | 15.31435887 | CS |
260 | -122.205 | -98.4730056406 | 124.1 | 200 | 1.88 | 786377 | 22.54200252 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales